How does the problem-oriented innovation system (PIS) help in the management of cardiovascular diseases?

Shohreh Nasri1, Javad Amani2, Gelayol Safavi1

  • 1Department of Science & Research Policy, National Research Institute for Science Policy, Tehran, Iran.

PubMed

Insights

Cardiovascular diseases (CVDs) in Iran can be managed by addressing governance and societal challenges. A problem-oriented innovation system (PIS) framework offers strategies for short, medium, and long-term control of CVDs.

Area of Science:

  • Public Health
  • Health Systems Research
  • Innovation Management

Background:

  • Cardiovascular diseases (CVDs) have become the leading cause of death in Iran since 1960, shifting from infectious diseases.
  • Managing CVDs as a grand challenge requires systematic, interdisciplinary, and innovative approaches within the health system.
  • The economic, social, and political systems of countries can be significantly impacted by the complexity of cardiovascular diseases.

Purpose of the Study:

  • To analyze cardiovascular diseases (CVDs) in Iran using a novel problem-oriented innovation system (PIS) framework.
  • To identify key governance-centered and society-driven challenges contributing to the CVD burden in Iran.
  • To provide evidence-based policy recommendations for managing and controlling CVDs in Iran.

Main Methods:

  • A library research approach was employed to identify challenges related to CVDs in Iran.
  • The problem-oriented innovation system (PIS) framework was utilized for analysis.
  • Challenges were categorized into "governance-centered" (policy, education, finance, personnel) and "society-driven" (diet, lifestyle, regulation, costs).

Main Results:

  • The study identified critical challenges in CVD management within Iran's health system.
  • Application of the problem-oriented innovation system (PIS) framework demonstrated that CVDs can be managed and controlled.
  • Effective management and control of cardiovascular diseases are achievable within short-term, medium-term, and long-term periods.

Conclusions:

  • Policy recommendations derived from the PIS framework can significantly improve CVD management in Iran.
  • Interventions include enhancing public awareness, fostering public-private partnerships for specialized centers, and implementing electronic health records.
  • Recommendations also encompass family health plans, promoting healthy food systems, expanding medical education capacity, and direct pharmaceutical subsidies for patients.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
323
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
1.1K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
144